News
In the Media
Blog
Careers
Contact Us
Home
About Us
Overview
Our Management Team
Board of Directors
Our Technology
Technology Overview
Publications
Disease Areas
Overview
Infectious Disease (viruses)
Infectious Disease (microbes)
Cancer
Product Pipeline
Success Stories
Humans make the best mAbs
Our discovery success in CMV treatment
Our Role in RSV Research
Our discovery success in Influenza treatment
2011 News Archive
2010 News Archive
2009 News Archive
2007 News Archive
2009 News Archive
December 01, 2009
Trellis Bioscience Grants MedImmune License for Its Anti-RSV Antibodies
